Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.
Fattori S, Le Roy A, Houacine J, Robert L, Abes R, Gorvel L, Granjeaud S, Rouvière MS, Ben Amara A, Boucherit N, Tarpin C, Pakradouni J, Charafe-Jauffret E, Houvenaeghel G, Lambaudie E, Bertucci F, Rochigneux P, Gonçalves A, Foussat A, Chrétien AS, Olive D. Fattori S, et al. Among authors: foussat a. Cancer Res. 2023 Sep 15;83(18):3026-3044. doi: 10.1158/0008-5472.CAN-23-0613. Cancer Res. 2023. PMID: 37379438 Free PMC article.
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.
Gauci ML, Giustiniani J, Lepelletier C, Garbar C, Thonnart N, Dumaz N, Foussat A, Lebbé C, Bensussan A, Marie-Cardine A. Gauci ML, et al. Among authors: foussat a. Cancer Immunol Immunother. 2022 Nov;71(11):2731-2742. doi: 10.1007/s00262-022-03199-0. Epub 2022 Apr 15. Cancer Immunol Immunother. 2022. PMID: 35428910 Free PMC article.
Pulmonary CCL18 recruits human regulatory T cells.
Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, Yssel H, Vorng H, Wallaert B, Tsicopoulos A. Chenivesse C, et al. Among authors: foussat a. J Immunol. 2012 Jul 1;189(1):128-37. doi: 10.4049/jimmunol.1003616. Epub 2012 May 30. J Immunol. 2012. PMID: 22649201
Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
Foussat A, Gregoire S, Clerget-Chossat N, Terrada C, Asnagli H, Lemoine FM, Klatzmann D, LeHoang P, Forte M, Bodaghi B. Foussat A, et al. J Ocul Pharmacol Ther. 2017 May;33(4):278-284. doi: 10.1089/jop.2016.0165. J Ocul Pharmacol Ther. 2017. PMID: 28448237 Review.
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF. Desreumaux P, et al. Among authors: foussat a. Gastroenterology. 2012 Nov;143(5):1207-1217.e2. doi: 10.1053/j.gastro.2012.07.116. Epub 2012 Aug 8. Gastroenterology. 2012. PMID: 22885333 Clinical Trial.
Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.
Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, Fall PB, Mausset-Bonnefont AL, Mantello-Moreau A, Rouquier S, Marchetti I, Jorgensen C, Foussat A, Louis-Plence P. Asnagli H, et al. Among authors: foussat a. Arthritis Res Ther. 2014 May 22;16(3):R115. doi: 10.1186/ar4567. Arthritis Res Ther. 2014. PMID: 24886976 Free PMC article.
Relationships of circulating CD4+ T cell subsets and cytokines with the risk of relapse in patients with Crohn's disease.
Duclaux-Loras R, Boschetti G, Flourie B, Roblin X, Leluduec JB, Paul S, Almeras T, Ruel K, Buisson A, Bienvenu J, Josson C, Jasnowski R, Legastelois S, Foussat A, Meunier C, Viret C, Rozieres A, Faure M, Kaiserlian D, Nancey S. Duclaux-Loras R, et al. Among authors: foussat a. Front Immunol. 2022 Nov 4;13:864353. doi: 10.3389/fimmu.2022.864353. eCollection 2022. Front Immunol. 2022. PMID: 36405740 Free PMC article.
72 results